Diabetes Care:HbA1c水平和BMI对1型糖尿病的血脂有什么影响?

2016-10-26 MedSci MedSci原创

探讨1型糖尿病患者从青少年时期进入到成年早期,糖化血红蛋白(HbA1c)和体重指数(BMI,测量值为BMI z评分[zBMI])对低密度脂蛋白(LDL)、高密度脂蛋白(HDL)和非HDL轨迹的影响。研究纳入572名青年1型糖尿病患者进行动态额回顾性队列研究,调查血脂值的变化,纵向的中位数时间为9.3年。通过纵向建模,我们描述HbA1c和zBMI与血脂值的关系,并且校正了其他相关因素,包括降脂药物的

探讨1型糖尿病患者从青少年时期进入到成年早期,糖化血红蛋白(HbA1c)和体重指数(BMI,测量值为BMI z评分[zBMI])对低密度脂蛋白(LDL)、高密度脂蛋白(HDL)和非HDL轨迹的影响。

研究纳入572名青年1型糖尿病患者进行动态额回顾性队列研究,调查血脂值的变化,纵向的中位数时间为9.3年。通过纵向建模,我们描述HbA1c和zBMI与血脂值的关系,并且校正了其他相关因素,包括降脂药物的使用。

脂质评估的中位数数量为7(范围2 - 39)。HbA1c每增加1%,LDL水平增加∼2–6 mg/dL,从青春期到青春期后期,LDL水平增加幅度更大。

BMI每增加1 SD,患者10岁时,平均LDL增加2.1 mg/dL,患者19岁时,平均LDL增加8.2 mg/dL。

HbA1c水平和zBMI对非HDL水平的影响,与LDL相似。

HbA1c水平和zBMI对HDL的影响较小,且不依赖于年龄。

结果表明,HbA1c水平和zBMI对LDL和HDL的影响较大,并且与年龄有关。1新糖尿病患者从儿童时期步入成年时期,应评估HbA1c水平和zBMI,以改善血脂情况。

原始出处:

Michelle L. Katz,et al.Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes.Diabetes Care 2016 Oct

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901487, encodeId=7645190148e6d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Apr 29 06:50:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015906, encodeId=554c201590684, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sun Oct 01 10:50:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637520, encodeId=0d2a163e520e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 25 22:50:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759799, encodeId=0fdc1e59799cc, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 06 12:50:00 CST 2017, time=2017-07-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901487, encodeId=7645190148e6d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Apr 29 06:50:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015906, encodeId=554c201590684, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sun Oct 01 10:50:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637520, encodeId=0d2a163e520e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 25 22:50:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759799, encodeId=0fdc1e59799cc, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 06 12:50:00 CST 2017, time=2017-07-06, status=1, ipAttribution=)]
    2017-10-01 Smile2680
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901487, encodeId=7645190148e6d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Apr 29 06:50:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015906, encodeId=554c201590684, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sun Oct 01 10:50:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637520, encodeId=0d2a163e520e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 25 22:50:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759799, encodeId=0fdc1e59799cc, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 06 12:50:00 CST 2017, time=2017-07-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901487, encodeId=7645190148e6d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sat Apr 29 06:50:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015906, encodeId=554c201590684, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sun Oct 01 10:50:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637520, encodeId=0d2a163e520e4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 25 22:50:00 CST 2017, time=2017-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759799, encodeId=0fdc1e59799cc, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Jul 06 12:50:00 CST 2017, time=2017-07-06, status=1, ipAttribution=)]

相关资讯

EASD 2016:降低HbA1c,能减少血管并发症风险

EASD 2016公布的寿命仿真模型数据显示,对于2型糖尿病和心血管疾病的成年患者,HbA1c每下降1%,微血管和大血管并发症的相对风险将降低。 来自牛津大学的Samiul A. Mostafa博士和同事们对5717例2型糖尿病和已知心血管疾病患者进行了研究,患这来自于TECOS试验(平均年龄66岁;女性占28%;85%的患者为白人;2型糖尿病病程11年;11%的患者为吸烟者)。 使用

Stroke:仅根据HbA1c诊断糖尿病不能预测卒中不良预后

背景:推荐应用糖化血红蛋白(HbA1c)来诊断糖尿病,但根据新标准初诊为糖尿病(NDDM)是否与卒中预后相关尚不清楚。研究者旨在探讨缺血性脑卒中的预后与按新标准诊断为NDDM的相关性。方法: 纳入中国急性卒中血糖调节异常研究中,无糖尿病病史的缺血性脑卒中患者进行调查分析。。NDDM定义为空腹血糖≥7 7.0 mmol/L,口服葡萄糖耐量试验2h时≥11.1 mmol/L,或糖化血红蛋白≥6.5%,

Diabetes Obes Metab:短期补充维生素D能否影响HbA1c?

先前有研究表明25(OH)D含量与2型糖尿病和冠状动脉存在风险呈负相关,但并没有估计两者间的因果联系。研究者对糖尿病风险增加的人群进行了一项研究,探究短期内服用维生素D补充剂对心血管代谢疾病的预后影响。该双盲安慰剂对照随机试验共纳入了340名2型糖尿病风险增加成年人(非糖尿病的高血糖症或糖尿病风险评分阳性),将其随机分为维生素D2 100,000 IU或维生素D3 100,000 IU和安慰剂组。

J Altern Complement Med:糖尿病患者福音,芦荟能降血糖!

根据最近的一项荟萃分析,口服芦荟可以降低前驱糖尿病和2型糖尿病患者的空腹血糖和HbA1c。利福尼亚特拉维斯空军基地格兰特空军医疗中心的William R. Dick药学博士和同事们分析了九项研究的数据,评估口服芦荟的摄入对前驱糖尿病和2型糖尿病患者的空腹血糖和HbA1c的影响。9项研究涉及空腹血糖数据(N = 283),5项研究涉及HbA1c数据N = 89)。3项研究涉及芦荟汁,1项研究使用芦荟

AJRCCM:持续气道正压通气可改善伴阻塞性睡眠呼吸暂停的2型糖尿病患者的血糖控制

据发表于American Journal of Respiratory and Critical Care Medicine的一项研究显示,对于血压难以控制的伴阻塞性睡眠呼吸暂停的2型糖尿病患者来说,持续气道正压通气治疗6个月可明显改善患者的血糖控制和胰岛素抵抗状况。

Diabetes Care:HbA1c和腰围是预测减肥术后糖尿病缓解程度的指标

目的 糖尿病患者行减肥手术的标准是BMI≥35kg/m2及血糖控制欠佳。然而,仅以BMI不能预测糖尿病的缓解程度,因此需要进一步明确能预测糖尿病缓解程度的指标。 研究设计及研究方法 从瑞典肥胖患者研究和两个随机对照研究中,一共挑选727名糖尿病患者入组,其中415名患者接受减肥手术治疗,而312名患者接受药物治疗。而减肥手术治疗组又分为胃减容术组和胃转流术组。 结果: